World

U.S. attorney general names special counsel in investigations relating to Trump

Nov 20, 2022

Washington (US), November 20: U.S. Attorney General Merrick Garland announced on Friday the appointment of a special counsel to oversee investigations relating to former President Donald Trump.
The announcement came days after Trump, a Republican, launched his third bid for the White House.
"Based on recent developments, including the former president's announcement that he is a candidate for president in the next election, and the sitting president's stated intention to be a candidate as well, I have concluded that it is in the public interest to appoint a special counsel," Garland said in a statement.
Sitting U.S. President Joe Biden, a Democrat who defeated Trump in the 2020 election, has said that he intends to seek re-election and that he would likely make an official decision "early next year."
Garland said Jack Smith, a former career prosecutor, will be the special counsel "to oversee two ongoing criminal investigations."
The first is an investigation into whether any person or entity unlawfully interfered with the transfer of power following the 2020 presidential election or the certification of the Electoral College vote held on or about Jan. 6, 2021.
The second is an ongoing investigation involving classified documents and other presidential records at Trump's Mar-a-Lago estate in Palm Beach, Florida, as well as the possible obstruction of that investigation.
"I will ensure that the special counsel receives the resources to conduct this work quickly and completely," Garland said.
Smith has resigned as chief prosecutor for the special court in The Hague to take the new role.
Trump has lashed out at a series of investigations involving him, alleging that they are politically motivated.
Source: Xinhua

More news

GV Safety Assessment Platform (GVSAP) and Biocytogen Forge Strategic Collaboration to Accelerate Biopharmaceutical Innovation

Hyderabad (Telangana) [India], May 17: GV Safety Assessment Platform (GVSAP), a leading integrated R&D enabler offering comprehensive preclinical research solutions, proudly announces a groundbreaking partnership with Biocytogen, a leader in industry-leading technologies that propel drug discovery. This collaboration marks a significant advancement in biomedical research, aimed at bolstering the R&D endeavors of Indian researchers by democratizing cutting-edge tools and technologies.

May 17, 2024